Impact of Risk Factors on Short and Long-Term Maternal and Neonatal Outcomes in Women With Gestational Diabetes Mellitus: A Prospective Longitudinal Cohort Study

Overview

Journal Front Endocrinol (Lausanne)

Specialty Endocrinology

Date 2022 Jul 7

PMID 35795139

Authors

Antonella Corcillo

Dan Yedu Quansah

Christophe Kosinski

Katrien Benhalima

Jardena J Puder

Affiliations

Soon will be listed here.

Abstract

Aims: Universal screening of gestational diabetes mellitus (GDM) in women with no risk factors (RF) for GDM remains controversial. This study identified the impact of the presence of RF on perinatal and postpartum outcomes.

Methods: This prospective cohort study included 780 women with GDM. GDM RF included previous GDM, first grade family history of type 2 diabetes, high-risk ethnicity and pre-pregnancy overweight/obesity (OW/OB). Outcomes included obstetrical, neonatal and maternal metabolic parameters during pregnancy and up to 1 year postpartum.

Results: Out of 780 patients, 24% had no RF for GDM. Despite this, 40% of them needed medical treatment and they had a high prevalence of glucose intolerance of 21 and 27% at 6-8 weeks and 1-year postpartum, respectively. Despite similar treatment, women with RF had more neonatal and obstetrical complications, but they had especially more frequent adverse metabolic outcomes in the short- and long-term. The most important RF for poor perinatal outcome were previous GDM and pre-pregnancy OW/OB, whereas high-risk ethnicity and pre-pregnancy OW/OB were RF for adverse postpartum metabolic outcomes. Increasing number of RF were associated with worsened perinatal and long-term postpartum outcomes except for pregnancy-induced hypertension, C-section delivery and neonatal hypoglycaemia.

Conclusion: Women with no RF had a high prevalence of adverse perinatal and postpartum outcomes, while the presence of RF particularly increased the risk for postpartum adverse metabolic outcomes. This calls for a RF-based long-term follow-up of women with GDM.

Citing Articles

Construction and validation of a line chart for gestational diabetes mellitus based on clinical indicators.

Wang H, Li Q, Wang H, Song W Lipids Health Dis. 2024; 23(1):349.

PMID: 39462412 PMC: 11514875. DOI: 10.1186/s12944-024-02334-3.

Postpartum glucose intolerance after gestational diabetes mellitus: tailored prediction according to data-driven clusters and BMI-categories.

Lesniara-Stachon A, Cosson E, Lacroix A, Schenk S, Quansah D, Puder J Front Endocrinol (Lausanne). 2024; 15:1381058.

PMID: 39081793 PMC: 11286585. DOI: 10.3389/fendo.2024.1381058.

The detection efficacy of noninvasive prenatal genetic testing (NIPT) for sex chromosome abnormalities and copy number variation and its differentiation in pregnant women of different ages.

Li Y, Yang X, Zhang Y, Lou H, Wu M, Liu F Heliyon. 2024; 10(2):e24155.

PMID: 38293423 PMC: 10826137. DOI: 10.1016/j.heliyon.2024.e24155.

References

Ryser Ruetschi J, Jornayvaz F, Rivest R, Huhn E, Irion O, Boulvain M . Fasting glycaemia to simplify screening for gestational diabetes. BJOG. 2016; 123(13):2219-2222. DOI: 10.1111/1471-0528.13857. View

Antoniou M, Gilbert L, Gross J, Rossel J, Fumeaux C, Vial Y . Main Fetal Predictors of Adverse Neonatal Outcomes in Pregnancies with Gestational Diabetes Mellitus. J Clin Med. 2020; 9(8). PMC: 7465343. DOI: 10.3390/jcm9082409. View

Quansah D, Gross J, Gilbert L, Arhab A, Horsch A, Puder J . Predictors and consequences of weight retention in the early and late postpartum period in women with gestational diabetes. Diabetes Res Clin Pract. 2020; 165:108238. DOI: 10.1016/j.diabres.2020.108238. View

Aubry E, Raio L, Oelhafen S . Effect of the IADPSG screening strategy for gestational diabetes on perinatal outcomes in Switzerland. Diabetes Res Clin Pract. 2021; 175:108830. DOI: 10.1016/j.diabres.2021.108830. View

Metzger B, Gabbe S, Persson B, Buchanan T, Catalano P, Damm P . International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010; 33(3):676-82. PMC: 2827530. DOI: 10.2337/dc09-1848. View

Barquiel B, Herranz L, Hillman N, Burgos M, Grande C, Tukia K . HbA1c and Gestational Weight Gain Are Factors that Influence Neonatal Outcome in Mothers with Gestational Diabetes. J Womens Health (Larchmt). 2016; 25(6):579-85. DOI: 10.1089/jwh.2015.5432. View

Ryan E . Diagnosing gestational diabetes. Diabetologia. 2011; 54(3):480-6. PMC: 3034033. DOI: 10.1007/s00125-010-2005-4. View

Papageorghiou A, Ohuma E, Altman D, Todros T, Ismail L, Lambert A . International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project. Lancet. 2014; 384(9946):869-79. DOI: 10.1016/S0140-6736(14)61490-2. View

Valizadeh M, Alavi N, Mazloomzadeh S, Piri Z, Amirmoghadami H . The risk factors and incidence of type 2 diabetes mellitus and metabolic syndrome in women with previous gestational diabetes. Int J Endocrinol Metab. 2015; 13(2):e21696. PMC: 4386229. DOI: 10.5812/ijem.21696. View

10.

Qiao Q, Hu G, Tuomilehto J, Nakagami T, Balkau B, Borch-Johnsen K . Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care. 2003; 26(6):1770-80. DOI: 10.2337/diacare.26.6.1770. View

11.

. 2. Classification and Diagnosis of Diabetes: . Diabetes Care. 2019; 43(Suppl 1):S14-S31. DOI: 10.2337/dc20-S002. View

12.

Quansah D, Gross J, Gilbert L, Helbling C, Horsch A, Puder J . Intuitive eating is associated with weight and glucose control during pregnancy and in the early postpartum period in women with gestational diabetes mellitus (GDM): A clinical cohort study. Eat Behav. 2019; 34:101304. DOI: 10.1016/j.eatbeh.2019.101304. View

13.

Blumer I, Hadar E, Hadden D, Jovanovic L, Mestman J, Murad M . Diabetes and pregnancy: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2013; 98(11):4227-49. PMC: 8998095. DOI: 10.1210/jc.2013-2465. View

14.

Ding T, Xiang J, Luo B, Hu J . Relationship between the IADPSG-criteria-defined abnormal glucose values and adverse pregnancy outcomes among women having gestational diabetes mellitus: A retrospective cohort study. Medicine (Baltimore). 2018; 97(43):e12920. PMC: 6221640. DOI: 10.1097/MD.0000000000012920. View

15.

Kim C, Newton K, Knopp R . Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002; 25(10):1862-8. DOI: 10.2337/diacare.25.10.1862. View

16.

Chiefari E, Quaresima P, Visconti F, Mirabelli M, Brunetti A . Gestational diabetes and fetal overgrowth: time to rethink screening guidelines. Lancet Diabetes Endocrinol. 2020; 8(7):561-562. DOI: 10.1016/S2213-8587(20)30189-3. View

17.

. 15. Management of Diabetes in Pregnancy: Standards of Medical Care in Diabetes-2022. Diabetes Care. 2021; 45(Suppl 1):S232-S243. DOI: 10.2337/dc22-S015. View

18.

Behboudi-Gandevani S, Parajuli R, Vaismoradi M . A Systematic Review of the Prevalence of Gestational Diabetes in Norway. Int J Environ Res Public Health. 2021; 18(4). PMC: 7913746. DOI: 10.3390/ijerph18041423. View

19.

Mirabelli M, Chiefari E, Tocci V, Greco E, Foti D, Brunetti A . Gestational diabetes: Implications for fetal growth, intervention timing, and treatment options. Curr Opin Pharmacol. 2021; 60:1-10. DOI: 10.1016/j.coph.2021.06.003. View

20.

Noctor E, Crowe C, Carmody L, Avalos G, Kirwan B, Infanti J . ATLANTIC DIP: simplifying the follow-up of women with previous gestational diabetes. Eur J Endocrinol. 2013; 169(5):681-7. DOI: 10.1530/EJE-13-0491. View